Código QR

Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors

Abstract Background Preclinical evidence from us and others demonstrates that the anticancer effects of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors can be enhanced with focal radiation therapy (RT), but only when RT is delivered prior to (rather than after) CDK4/6 inhibition. Depending on tumor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vanessa Klapp, Aitziber Buqué, Norma Bloy, Ai Sato, Takahiro Yamazaki, Xi Kathy Zhou, Silvia C. Formenti, Lorenzo Galluzzi, Giulia Petroni
Formato: Artigo
Lenguaje:Inglês
Publicado: BMC 2023-02-01
Colección:Journal of Translational Medicine
Materias:
Acceso en línea:https://doi.org/10.1186/s12967-023-03964-4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!